Did you know that over 4.3 billion prescriptions were filled last year in the U.S. alone, yet less than 50% were effective as prescribed? It’s time to do something about it — and we’re incredibly honored to help.
Russell Herder has been named agency of record for OneOme, a privately held company backed by Invenshure, LLC and co-developed and exclusively licensed from Mayo Clinic. We’re creatively and strategically helping introduce this industry-changing innovation to pharmacists, providers, health system administrators and consumers.
Driven to improve patient care and reduce overall healthcare costs, OneOme recently announced global availability of the RightMed™ pharmacogenomic (PGx) test. Across more than 340 medications for more than 20 medical indications, this cost-effective, comprehensive test helps healthcare providers easily make timely, evidenced-based, personalized prescription treatment decisions. OneOme is partnering with leading health systems across the U.S., Puerto Rico, Cuba, and the Dominican Republic.
The OneOme RightMed™ PGx test can be ordered by a provider through their online portal. OneOme will send the DNA prescription test kit — a simple cheek swab test — to the patient’s home. After the patient returns their sample in the pre-paid envelope and OneOme completes the analysis, the ordering provider will have access to a clear, actionable report through the portal.
Healthcare of the future. Available today.
